Release Date: 27/07/20 08:16 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 2.38MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%